Condition: Multiple Myeloma · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to provide ongoing access to study treatments for participants with multiple myeloma or smoldering multiple myeloma benefiting from treatment in certain Janssen Research and Development (R\&D) studies that use daratumumab as part of the study treatment regimen: access for all participants regardless of treatment group in daratumumab studies and access to participants in daratumumab-containing arms in the non-daratumumab studies will be allowed from studies which have reached clinical cutoff for final analysis. Certain long-term safety data will continue to be collected from study participants.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Miami Sylvester Cancer Center | Miami, Florida, United States | — |
| Emory University | Atlanta, Georgia, United States | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor, Michigan, United States | — |
| Barnes-jewish Hospital | St Louis, Missouri, United States | — |
| Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg | New York, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| Baylor University Medical Center | Dallas, Texas, United States | — |
| ZAS Cadix | Antwerp, Belgium | — |
| UNICAMP | Campinas, Brazil | — |
| Liga Norte Riograndense Contra O Cancer | Natal, Brazil | — |
| Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS | Porto Alegre, Brazil | — |
| Ministerio da Saude Instituto Nacional do Cancer | Rio de Janeiro, Brazil | — |
+ 80 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.